NL171986C - Werkwijze voor het bereiden en/of vervaardigen van geneesmiddelen, die een 6-aza-3h-1,4-benzodiazepine bevatten, alsmede de gevormde geneesmiddelen. - Google Patents
Werkwijze voor het bereiden en/of vervaardigen van geneesmiddelen, die een 6-aza-3h-1,4-benzodiazepine bevatten, alsmede de gevormde geneesmiddelen.Info
- Publication number
- NL171986C NL171986C NLAANVRAGE7216621,A NL7216621A NL171986C NL 171986 C NL171986 C NL 171986C NL 7216621 A NL7216621 A NL 7216621A NL 171986 C NL171986 C NL 171986C
- Authority
- NL
- Netherlands
- Prior art keywords
- medicinal products
- benzodiazepine
- aza
- preparing
- manufacturing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/63—One oxygen atom
- C07D213/64—One oxygen atom attached in position 2 or 6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/57—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/61—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT1060471A AT333284B (de) | 1971-12-09 | 1971-12-09 | Verfahren zur herstellung von neuen 6-aza-3h-1,4-benzodiazepinen, deren optischen isomeren und deren salzen |
Publications (3)
Publication Number | Publication Date |
---|---|
NL7216621A NL7216621A (no) | 1973-06-13 |
NL171986B NL171986B (nl) | 1983-01-17 |
NL171986C true NL171986C (nl) | 1983-06-16 |
Family
ID=3623479
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NLAANVRAGE7216621,A NL171986C (nl) | 1971-12-09 | 1972-12-07 | Werkwijze voor het bereiden en/of vervaardigen van geneesmiddelen, die een 6-aza-3h-1,4-benzodiazepine bevatten, alsmede de gevormde geneesmiddelen. |
Country Status (26)
Country | Link |
---|---|
JP (4) | JPS569509B2 (no) |
AR (3) | AR201201A1 (no) |
AT (4) | AT332877B (no) |
AU (1) | AU473253B2 (no) |
BE (1) | BE792541A (no) |
CH (4) | CH594665A5 (no) |
CS (1) | CS212736B2 (no) |
DD (1) | DD105448A5 (no) |
DE (1) | DE2259471C2 (no) |
DK (1) | DK138425B (no) |
EG (1) | EG10918A (no) |
ES (2) | ES409090A1 (no) |
FI (1) | FI54710C (no) |
FR (1) | FR2162482B1 (no) |
GB (1) | GB1400755A (no) |
HU (1) | HU169468B (no) |
IL (1) | IL41034A (no) |
IT (1) | IT1035053B (no) |
NL (1) | NL171986C (no) |
NO (1) | NO137094C (no) |
PL (3) | PL91828B1 (no) |
RO (4) | RO67345A (no) |
SE (1) | SE404803B (no) |
SU (4) | SU468423A3 (no) |
YU (2) | YU305972A (no) |
ZA (1) | ZA728497B (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2364636C2 (de) * | 1973-12-24 | 1982-11-04 | Degussa Ag, 6000 Frankfurt | Verfahren zur Herstellung von 2-Benzoyl-6-chlor-3-nitro-pyridinen |
ATE7295T1 (de) * | 1980-01-16 | 1984-05-15 | Lacer, S.A. | 2-halo-pyridine, ihre herstellung und pharmazeutische zusammensetzungen. |
JPS60132610A (ja) * | 1983-12-20 | 1985-07-15 | Japan Organo Co Ltd | 汚泥脱水装置 |
JPS6219221A (ja) * | 1985-07-16 | 1987-01-28 | Chiyoda Chem Eng & Constr Co Ltd | 原液中の微細粒子を除去する濾過方法と濾過装置 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3314941A (en) * | 1964-06-23 | 1967-04-18 | American Cyanamid Co | Novel substituted pyridodiazepins |
US3523939A (en) * | 1967-07-03 | 1970-08-11 | Hoffmann La Roche | 5-(2,6-disubstituted phenyl)-1,4-benzodiazepines and methods for their preparation |
-
1971
- 1971-12-09 AT AT902174A patent/AT332877B/de active
- 1971-12-09 AT AT902274A patent/AT332878B/de active
- 1971-12-09 AT AT1060471A patent/AT333284B/de not_active IP Right Cessation
-
1972
- 1972-11-29 ES ES409090A patent/ES409090A1/es not_active Expired
- 1972-11-29 ES ES409089A patent/ES409089A1/es not_active Expired
- 1972-11-30 ZA ZA728497A patent/ZA728497B/xx unknown
- 1972-11-30 FI FI3390/72A patent/FI54710C/fi active
- 1972-12-05 SE SE7215858A patent/SE404803B/xx unknown
- 1972-12-05 DE DE2259471A patent/DE2259471C2/de not_active Expired
- 1972-12-06 EG EG502/72A patent/EG10918A/xx active
- 1972-12-06 FR FR7243359A patent/FR2162482B1/fr not_active Expired
- 1972-12-06 HU HUDE799A patent/HU169468B/hu unknown
- 1972-12-07 IT IT7254583Q patent/IT1035053B/it active
- 1972-12-07 RO RO7281197A patent/RO67345A/ro unknown
- 1972-12-07 RO RO7281195A patent/RO65264A/ro unknown
- 1972-12-07 PL PL1972175582A patent/PL91828B1/pl unknown
- 1972-12-07 PL PL1972159365A patent/PL89682B1/pl unknown
- 1972-12-07 NL NLAANVRAGE7216621,A patent/NL171986C/xx not_active IP Right Cessation
- 1972-12-07 PL PL1972175581A patent/PL91876B1/pl unknown
- 1972-12-07 RO RO7200073075A patent/RO62312A/ro unknown
- 1972-12-07 RO RO7281196A patent/RO65263A/ro unknown
- 1972-12-08 DK DK615172AA patent/DK138425B/da not_active IP Right Cessation
- 1972-12-08 NO NO4536/72A patent/NO137094C/no unknown
- 1972-12-08 CS CS728424A patent/CS212736B2/cs unknown
- 1972-12-08 IL IL41034A patent/IL41034A/en unknown
- 1972-12-08 YU YU03059/72A patent/YU305972A/xx unknown
- 1972-12-08 GB GB5688372A patent/GB1400755A/en not_active Expired
- 1972-12-08 BE BE792541A patent/BE792541A/xx not_active IP Right Cessation
- 1972-12-08 SU SU1855103A patent/SU468423A3/ru active
- 1972-12-09 JP JP12387872A patent/JPS569509B2/ja not_active Expired
- 1972-12-11 AU AU49931/72A patent/AU473253B2/en not_active Expired
- 1972-12-11 CH CH1794972A patent/CH594665A5/xx not_active IP Right Cessation
- 1972-12-11 DD DD167428A patent/DD105448A5/xx unknown
- 1972-12-11 CH CH1506576A patent/CH605946A5/xx not_active IP Right Cessation
- 1972-12-11 CH CH1526076A patent/CH603645A5/xx not_active IP Right Cessation
- 1972-12-11 CH CH1506676A patent/CH603644A5/xx not_active IP Right Cessation
-
1973
- 1973-09-10 AR AR250008A patent/AR201201A1/es active
-
1974
- 1974-03-20 AR AR252867A patent/AR200309A1/es active
- 1974-07-08 SU SU7402042686A patent/SU564809A3/ru active
- 1974-07-08 SU SU742041603A patent/SU674675A3/ru active
- 1974-10-15 SU SU7402067128A patent/SU574156A3/ru active
- 1974-10-31 AR AR256352A patent/AR203311A1/es active
- 1974-11-11 AT AT902074A patent/AT338798B/de not_active IP Right Cessation
-
1980
- 1980-04-15 JP JP5022180A patent/JPS5625180A/ja active Granted
- 1980-04-15 JP JP5022280A patent/JPS55147282A/ja active Granted
- 1980-04-15 JP JP5022380A patent/JPS5625181A/ja active Granted
-
1981
- 1981-05-07 YU YU01168/81A patent/YU116881A/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NL178965C (nl) | Werkwijze voor de bereiding van geneesmiddelen met beta-adrenolytische werking, gevormde geneesmiddelen die deze bevatten, en werkwijze voor de bereiding van verbindingen met deze werking. | |
NL7416022A (nl) | Werkwijze voor het bereiden van een geneesmid- del, zo gevormd geneesmiddel en werkwijze ter bereiding van de daartoe vereiste geneeskrach- tige verbindingen. | |
NL166939C (nl) | Werkwijze voor het bereiden van geneesmiddelen met een gunstige invloed op de bloedsomloop, alsmede werkwijze voor het bereiden van daarvoor geschikte actieve verbindingen. | |
NL173641C (nl) | Werkwijze voor het bereiden of vervaardigen van een geneesmiddel. | |
NL169262C (nl) | Werkwijze voor het conserveren van plantaardige produkten, alsmede werkwijze voor het bereiden van een daarbij gebruikt conserveermiddel. | |
NL181801C (nl) | Werkwijze voor het bereiden van geneeskrachtige verbindingen op basis van 1,1-difenyletheenderivaten, en voor de bereiding van geneesmiddelen, die deze verbindingen bevatten. | |
NL7700637A (nl) | Werkwijze voor het bereiden van gestogeenesters, alsmede geneesmiddelen, die deze esters bevatten. | |
NL161444C (nl) | Werkwijze voor de bereiding van een geneesmiddel met an- ti-arrhytmische werking, gevormd geneesmiddel met een degelijke werking en werkwijze voor de bereiding van een ureumderivaat. | |
NL152171B (nl) | Werkwijze voor het bereiden van een geneesmiddel met vaatverwijdende eigenschappen, alsmede gevormd geneesmiddel. | |
NL151404B (nl) | Werkwijze voor het bereiden van een polyester, alsmede daarvan vervaardigd gevormd voortbrengsel. | |
NL170733C (nl) | Werkwijze voor het bereiden of vervaardigen van een geneesmiddel en werkwijze voor het bereiden van een geneeskrachtige verbinding. | |
NL171986C (nl) | Werkwijze voor het bereiden en/of vervaardigen van geneesmiddelen, die een 6-aza-3h-1,4-benzodiazepine bevatten, alsmede de gevormde geneesmiddelen. | |
NL7601019A (nl) | Werkwijze voor de bereiding van 5h-di- benzo (a,d) cyclohepteencarbonamiden en 10,11-di- hydro-5h-dibenzo (a,d)-cyclohepteencarbonamiden, een werkwijze voor de bereiding van een geneesmid- del met anti-arytmische en anti-hypertensieve wer- king alsmede een dergelijk geneesmiddel. | |
NL176142C (nl) | Werkwijze voor het bereiden van pijnstillende en ontstekingsremmende geneesmiddelen, alsmede een daarvoor geschikt acetylsalicylzuur houdend coprecipitaat. | |
NL161150C (nl) | Werkwijze voor het bereiden van een geneesmiddel, alsmede verkregen gevormd geneesmiddel en werkwijze voor het bereiden van een benzofuranverbinding. | |
NL7312032A (nl) | Werkwijze voor het bereiden en toedienen van een diergeneesmiddel. | |
NL174944C (nl) | Werkwijze voor het bereiden of vervaardigen van een geneesmiddel met antibiotische werkzaamheid, alsmede werkwijze voor het bereiden van een hetacilline verbinding. | |
NL152585B (nl) | Werkwijze voor de bereiding van een siloxancopolymeer, werkwijze voor het bereiden van schuimstoffen, alsmede de daaruit vervaardigde voorwerpen. | |
NL151994B (nl) | Werkwijze voor de bereiding van cefalosporine met antibiotische werking, werkwijze voor de bereiding van een geneesmiddel met een dergelijke werking en gevormd geneesmiddel. | |
NL7408875A (nl) | Werkwijze voor de bereiding van alkalipolyfos- faatcomplexen met antibiotische werking, werk- wijze voor de bereiding van een geneesmiddel met een dergelijke werking en een dergelijk geneesmiddel. | |
NL177309C (nl) | Werkwijze voor de bereiding van een geneesmiddel en werkwijze voor de bereiding van 1-gesubstitueerde pyrazoolverbindingen. | |
NL157314B (nl) | Werkwijze voor het bereiden van een 3-oxo-13beta-r-17alfa-x, 17beta-hydroxy-gona-4,9,11-trieen, alsmede werkwijze voor het bereiden van een geneesmiddel en onder toepassing daarvan verkregen gevormd geneesmiddel. | |
NL179056C (nl) | Werkwijze voor het bereiden van geneesmiddelen met een anti-allergische en ontstekingsremmende activiteit, alsmede daarvoor geschikte, geneeskrachtige verbindingen. | |
NL7416074A (nl) | Werkwijze voor het bereiden van 1-amino-5,6-di- hydro-morfanthridin-5,11-dion-verbindingen, werkwijze voor het bereiden van geneesmiddelen, alsmede de gevormde geneesmiddelen. | |
NL169177C (nl) | Werkwijze voor het bereiden of vervaardigen van een geneesmiddel met werking op het cardiovasculaire systeem, alsmede werkwijze voor het bereiden van daarvoor geschikte geneeskrachtige arylalkylamidinederivaten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DNT | Communications of changes of names of applicants whose applications have been laid open to public inspection |
Free format text: DEGUSSA AKTIENGESELLSCHAFT |
|
V1 | Lapsed because of non-payment of the annual fee |